Alternative pricing strategies for cancer drugs

JAMA. 2015 Feb 24;313(8):857. doi: 10.1001/jama.2014.17814.

Authors

Andrea Messori¹, Mauro De Rosa², Luca Pani³

Affiliations

¹ Health Technology Assessment Unit, Regional Health Service, Firenze, Italy.
² Italian Society of Clinical Pharmacy and Therapeutics, Milan, Italy.
³ Italian Medicines Agency, Rome, Italy.

PMID: 25710668
DOI: 10.1001/jama.2014.17814

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / economics*
Drug Costs*

Substances

Antineoplastic Agents